EDGAR Filing Documents for 0001615219-23-000042

Form 8-K - Current report:

SEC Accession No. 0001615219-23-000042

Filing Date

2023-05-16

Accepted

2023-05-16 16:33:13

Documents

Period of Report

2023-05-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	flks-20230511.htm iXBRL	8-K	56606
2	EX-4.1	exhibit411.htm	EX-4.1	119922
3	EX-4.2	exhibit42.htm	EX-4.2	115299
4	EX-4.3	exhibit43.htm	EX-4.3	118907
5	EX-10.1	exhibit1011.htm	EX-10.1	303013
6	EX-10.2	exhibit1021.htm	EX-10.2	165118
7	EX-99.1	a051223slrx-pipepricingxfi.htm	EX-99.1	14135
11		image_0.jpg	GRAPHIC	77186
12	EX-99.2	slrx-pipeclosingprv1.htm	EX-99.2	13476
	Complete submission text file	0001615219-23-000042.txt		1326605

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	flks-20230511.xsd	EX-101.SCH	1924
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	flks-20230511_lab.xml	EX-101.LAB	23892
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	flks-20230511_pre.xml	EX-101.PRE	12541
14	EXTRACTED XBRL INSTANCE DOCUMENT	flks-20230511_htm.xml	XML	11337

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021

Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346

Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)